Innova Captab Limited has announced its Investor Presentation for the Analysts/Institutional Investor Meeting to discuss the financial results for the quarter and financial year ended March 31, 2026. This follows the intimation of an Earnings Call scheduled for May 8, 2026, at 11:00 A.M. (IST). The company reported robust financial performance for FY26, with revenues reaching ₹1,630 Crore, a year-on-year growth of 31%. EBITDA stood at ₹250.3 Crore (15.4% margin), and Profit After Tax (PAT) was ₹140.9 Crore (8.6% margin). The company highlighted a strong YoY revenue growth of 42% in Q4 FY26 and 31% in FY26, driven by sustained momentum in both its CDMO and branded generics businesses. Exports contributed 31% to the overall revenue in FY26. The MD's commentary emphasized the highest-ever annual revenue and strong performance across operations, supported by an expanding product portfolio and increasing customer engagement. Key certifications, including UK-MHRA for the Baddi facility and PIC/S for the Jammu facility, were received, enhancing presence in regulated markets. The Jammu facility has completed its first full year of operations and is ramping up well. The presentation also detailed the company's journey, manufacturing capabilities across multiple sites (Baddi, Dehradun, Taloja, Kathua), key accreditations, and a comprehensive business model serving over 350 CDMO customers globally and a network of 2,50,000+ touchpoints in India. The company's R&D efforts and experienced management team were also highlighted.
